IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Fine Chemicals: A Promising Outlook

2:21 PM MDT | October 17, 2011 | —DEEPTI RAMESH

The outlook for contract manufacturers looks promising despite cost pressures and increased competition, pharmaceutical ingredient manufacturers say. Active pharma ingredient (API) and pharma intermediate producers plan further expansion of their activities, including investments in new geographies. Regulatory bodies, meanwhile, are tightening their scrutiny of the sector. Hardy: Plans to establish a manufacturing presence in Asia and U.S. in 2012. The $40-billion/year global API market is expected to grow 4%-5%/year in volume terms and 0%-1%/year in value terms...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa